Feeds:
Posts
Comments

Logic would suggest  any two structures  in close proximity can have  some sort of anatomical , physiological or sometimes pathological relationship .Esophagus and heart  share a strategic  anatomical  space within the mediastinum  . The left atrial wall  is abetting the esophagus with only few millimeters separating the two. Trans esophageal  echocardiography has utilised this proximity for it’s  advantage . With the probe in esophagus we can get a  100%  interior view of left atrium . Both these structures can mutually compress one another at times of pathology . ( LA compression on esophagus in mitral stenosis , Esophageal compression of LA in hiatus hernia or esophageal growths) . Now ,  we also  realise , esophagus  a   functionally unrelated structure  to  cardiovascular system  can have a impact on cardiac functioning.

Hiatus hernia of gastroesophageal junction can mechanically compress the posterior aspect of heart and result in atrial  arrhythmias and pericarditis  ?

Reference

1 Duygu H, Ozerkan F, Saygi S, et al. Persistent atrial fibrillation associated with
gastroesophageal refl ux accompanied by hiatal hernia. Anadolu Kardiyol Derg
2008; 8(2):164-165.

A case report from South africa

http://www.saheart.org/journal/index.php?journal=SAHJ&page=article&op=view&path[]=115&path[]=109

Read further for esophagus- heart  stories.

  • Esophageal ulcers , spasm can trigger electrical activity that can mimic cardiac event  or rarely precipitate a real angina  , what is often referred to as  linked angina .
  • A rare case of pneumopericardium due to rupture of esophagus into pericardial space
  • ST elevation in ECG due to esophageal spasm

http://www.drsvenkatesan.com

cardiologist Is he a person who puts  a   metal coil  coated with a synthetic fungus   in  a   incidentally  detected  block  inside a  small coronary artery and sends the bill to the Insurance company ?

Is he a person in a  cosmopolitan  hospital  who opens up a    chronically   closed  coronary artery , in an asymptomatic patient  and  live telecasts  his achievement trans continentally ?

Is he a person who   checks in by  the early morning flight and  puts multiple wires in  an  aged   patient   with  class 3 heart failure and  make  him walk  20 meters extra at a cost of  1000$ / Meter ?

Is he a person living in   Wall   street  ,   who   looks  for variety of holes In  the heart and trying to occlude  it  with   exotic   devicespci ptca stent

Is he the unknown   physician   who Intervenes in the natural history of Rheumatic heart disease   and arrests   immune mediated   valve damage by giving the  monthly injections  penicillin in remote parts of our country ?

Is he the person   who   Intervenes to prevent young   persons   from  smoking and help maintain  their  coronary endothelium  enriched with nitric oxide  & arrest  the coronary epidemic ?

cardiologist 2

Is he the small town doctor  who  Intervenes  to treat a breathless cardiac failure patient  with  digoxin and frusemide  and  dramatically alleviate the  symptoms and  prolong the  life of our poor country men?

Is she the village health nurse from an inaccessible health  centre  located in a  hilly terrain ,  Intervening  successfully, by   pulling out  live babies  from  severely anemic pregnant  mothers with failing hearts ?

pci ptca cardiologist coronary angiograms

Early repolarisation syndrome, (Also called ERS) is a common ECG observation among general population.It is diagnosed when  ST elevation occurs   with concavity upwards in anterior chest leads and inferior leads or both. The exact  incidence is variable (Up to 2%). It forms an important variant in young males .Females form a minority  with this finding.

The ST segment instead of  staying at baseline drift superiorly .The descending limb of qrs ,  ie the S wave is  prematurely interrupted as it travels downhill before reaching the baseline , the ST segment is inscribed resulting in a elevated ST segment.

ers early repolarisation syndrome

What is the mechanism ?

ST segment represents the major part of  ventricular  repolarisation. The ionic channel responsible forthis current is K+ efflux from the cells. The potassium channel opening determines the speed with which replorisation happens. The kinetics  K+ channels are  greatly dependent on genetic inheritance (As do long qt syndromes) .The high degree of variance of ST morphology in normal population is attributed to potassium channel heterogeneity.

Is ERS a benign entity ?

For long . . .we believed so !  now evidence indicates it may not be . . .

early repolarisation syndrome ers ecg  primary vf

The importance of ERS  not lies in it’s ECG appearance , the fact that ,  it occurs in a critical time of cardiac cycle makes it a potential threat. We know ST segment encloses the   electrically  unstable  QT interval .Any alteration in it’s morphology can trigger a electrical heterogeneity. In fact there is some truth in the observation ERS prolongs the QT interval when compared to controls.

Haissagure has elegantly studied this issue in NEJM and provided evidence ERS may have a strong propensity for ventriculaarrhytmias (Read below)

But , there is no need to panic , ERS  is still considered benign, but  waht is posible is persons with  this abnormality could be prone for primary VF when confronted with a episode of ischemia.

What is exercise response in ERS patients?

One of the following can occur.

  1. ST segment normalises
  2. Stays  elevated
  3. Junctional depression

ST segment normalisation is the expected response. Some believed the resting ST elevation tend to prevent the true ST depression in times of ischemia  . Often , classical ischemic ST depression can occur in  patients with CAD.

Dynamic ERS

The most tricky finding is fluctuation in ST segment magnitude with reference to vagal tone, heart rate can occur.This can mimic a coronary syndrome , and enzyme levels are necessary to rule out .

Reference

1.Haïssaguerre M, Derval N, Sacher F et al. Sudden cardiac arrest
associated with early repolarization. N Engl J Med, 2008; 358:
2063–2065.

2. Early repolarization syndrome: Is it always benign?
International Journal of Cardiology, Volume 114, Issue 3, Pages 390-392
K. Letsas, M. Efremidis, L. Pappas, G. Gavrielatos, V. Markou, A. Sideris, F. Kardaras

Link to the best  review article on ERS

http://www.viamedica.pl/gazety/gazeta1/darmowy_pdf.phtml?indeks=97&indeks_art=1264

Fundamental principle  of  human biological system is to live in harmony with nature and environment.Each cell  has a unique reaction  when it comes into contact with  external  material. This reaction can be acute or chronic  ,   local or systemic. The most severe form of allergy is called anaphylaxis  that can result in instantaneous loss of life. There  is a whole gamut of disorders  that  resulted  in a  separate  speciality called allergic medicine .

Further ,the transplantation  science have   taught us  an  organ or cell can be rejected at any point of time after implantation (Hyperacute -chronic) .With advancement of science we have started implanting a variety of devices  with complex metallurgy ,inside human body, metal clips, prosthesis, valves, wires, etc .How the body handles them .The consequences can be a mild reaction to major ones occasionally.

Consider ,a local allergy due to a orthopedic prosthesis  in one of the leg bones  is far less serious than a metal within a coronary artery  irritating the intima .

Remember hypersensitivity reactions can be severe . This lady reacted  like this to a sandal slipper -A  fiery red  infiltration

contact dermatits stent allergy pci coronary

Imagine  if a stented coronary artery react like this what would be the possible consequence ?

In susceptible  individuals  , can a metal cause

  • Intimal hyperemia
  • Intimal induration
  • Intimo-medial edema  following stent deployment

pci stent coronary angiogram thrombosis des

Why drug eluting stents are more prone for hypersensitivity ?

The answer is simple , while metal allergy is a comparatively rare phenomenon, the drugs we  coat and the polymers used are  many fold likely to result in hypersensitivity reaction.

While  the world is worried  more  about penicillin , sulpha allergy which occurs in 1 in 100000 ,  we tend to ignore the metal and drug  reactions within  the tender coronary arteries.

stent des rejection virmani  pci

What is  the clinical expression of  stent hypersensitivity ?

It is  often a coronary event in the acute phase and restenosis in chronic phase.

How much of acute stent thrombosis is related to stent allergy mediated reaction ?

The exact incidence  will  never be known. It could be high. Whenever a sudden unexpected early stent occlusion can be a suspect .

Is stent allergy a local reaction or systemic reaction ?

It is most often local .The drugs the stent elute can elicit a systemic reaction occasionally.

So what can be done to prevent this complication ?

Drug companies in it’s  package regularly  include the warning  message ! What does it imply to have a caution  on the covers ? .This warning simply represent about our ignorance in this issue. We presume it is a minor problem.

pci stent thrombosis stent allergy metal

Questions unanswered

  1. How does a cardiac patient knows whether he is hypersensitive to stainless steel or nickel ?
  2. Is it practical to have a stent allergic test in every patient before PCI ?
  3. Is routine administration of corticosteroids for few days after PCI an answer ?

Reference

R.Virmani , circulation 2004

http://circ.ahajournals.org/cgi/content/full/109/6/701?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=stent+%27allergy%22+&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT

Atrial  septal defects  are one of the commonest forms of congenital heart disease.

  • The commonest being the ositum secundum ASD     ( Which is in fact is a defect in the development of septum primum)
  • The next common is ostium primum defect which is a part of AV canal or atrio ventricular septal defect.

Other forms of ASD include

  • SVC type /Also  called sinus venosus type of ASD .
  • IVC type
  • Coronary sinus defect -Also called partial or complete forms of unroofed coronary sinus

asd svc asd sinus venosus

SVC type ASDs

They are in the strict sense can not be called as ASD. This is because there is no defect in  any of the  embryological  inter atrial septal component.

There is no direct communication between RA and LA, instead   a window  or passage of communication   between pulmonary vein and SVC. Right upper lobe pulmonary vein  is usually the culprit .Some times more than one PV  communicates with SVC.

The exact area of this PV-SVC window occur between anterior surface of right upper lobe PV with postero lateral surface of SVC.

PAPVC partial anomalous pulmonary venous drainage can be considered an integral part of this defect as RUPV is linked with SVC.

Can we have a combination of SVC ASD and OS ASD ?

This is possible .But two embryological errors need to occur. This is often seen as a large OS ASD with deficient or absent superior rim. So whenever superior rim of IAS is deficient a PAPVC and a SVC ASD should be looked for.

Clinical features

  • SVC type ASDs  generally shunt lesser blood than OS ASDs. (Often<2:1) .This is because it is not the LA that is communicating with RA instead only a
  • It is usually a single PV (some times 2) that shunts from left to right.

There is a distinct possibility of missing this lesion in routine echo.Minimal RA,RV enlargement may give us a clue.The classical subcostal or  4 chamber  view in echocardiography may not visualise  these defects.

So, whenever one encounters mild dilatation  of RA and RV and the IAS appears  intact, a meticulous search and a focused echo in the superior aspect of IAS is warranted. Angled  superior views may pick up this defect.A transesophageal echocardiogram (TEE) is often required to  confirm it.

Therapeutic issues

  • Device closure is not possible
  • Surgery involves little more technicality than ASD OS.
  • Small defects can be patch closed.
  • Some times the SVC has to be disconnected from the PV and anastamosed separately on right atrial appendage. SVC resection  will  aid the surgeon in proper patch closure.
  • Post operative follow up is necessary as SVC obstruction or PV obstruction may be a delayed consequence

References

svc asd sinus venosus

http://ats.ctsnetjournals.org/cgi/content/full/59/6/1588?ijkey=4f42649bc5805f3cf7d60f5728ec7f871356277b

http://asianannals.ctsnetjournals.org/cgi/content/full/10/3/231

Research is the  guiding force for advancement in medical science.New drug and devices are developed every year that result in major break throughs.There need to be  a strong purpose and meaning for every research concepts in Medicine.The fundamental  principle in medical research  should be . . .

In basic science

It need to  generate a  new concept  that should help solve a existing  problem  or find an  eluding  answer ( Eg mechanism of an organ or cell function,  Genetic research  etc)

In clinical science

  1. An applied scientific concept  that can generate new treatment  modalities.
  2. Development of new diagnostic tools that can add new information to the existing imaging modalities.It should have either a cost or effectiveness advantages .
  3. Development of new drugs  or devices or surgical methods with  less side effects.
  4. Development of new drugs, which has a new additional benefit with less side effects.

A .What is Junk research or duplication of research

Most of the research methods testing  “non inferiority”  hypothesis can be considered junk  research (Note – Exceptions will be there. )

The most exploited concept in drug research  is  the concept of testing   non inferiority as it  allows comparing  new drugs with a proven old  drugs .Why should some one produce a drug which is likely to have a same effect  with  no additional benefit. Huge amount of time  , money  efforts  are wasted in  such  research

What is the need for 20 different ACE inhibitors  and 10 different ARBs when the basic structure  and function is almost similar ? Similarly Statins, analgesics, H2 receptor blockers, various forms of heparin  the list is end less . . .

There need to be a  strict vigil  on which research question the industry is trying to raise  and answer ?

Drug are released periodically  like movies with same old  screen play ( With a new  name  of course !) but with   a huge  cost.If any novel or music or art work or done in similar fashion there is  vibrant media to expose it, or  some times even legal action follows.  Alas . . . In medicine  it is free for all as  any one can legally plagiarise with  loopholes in plenty. Some times these drugs are hurriedly marketed as it has to generate the funds  before risk of it getting banned due to unforeseen side effects. In this sense some drugs exactly mimic a movie with good box office run for the initial few weeks.

A autonomous  world body ( Say WHO ) should supervise which research can be pursued in this world that can help betterment of human health . Currently tighter  regulations come into force only  during human testing .We need act  earlier   to prevent junk research in lab itself ! This can save huge resources .Some  may argue ,scientific work should not be curtailed  however futile they are !  I leave it your judgement .

B.Placebo compared superiority : This is another controversial concept  .This was a prerequisite  for a drug research in the earlier era .Now a drug need to be compared with the best current treatment! not with placebo.

Why superiority studies  are rarely designed by drug companies ?

Realise , how rare it would be to find  a study   where  a patented drug  is  compared  for superiority over another patented drug . Can you  guess the reason . . .  because they can do  superiority studies  easily over the placebos  !

Do we need to restrict drug development with similar structure and function?

The only argument can be in a global economy no body has a right to prevent any company  from  producing whatever they want  to  ! Survival of such  drugs  in this world is left to  market forces .The consequence  such approach could be disastrous ,  as  the  cheap  generic drugs with a  maximal  proven beneficial effect (Eg Hydrocholrthiazide in Hypertension ,  ) may not be manufactured at all in the near future . (Link to msf)

Is  the need for choices ,  an excuse ?

Like any commodity , people need choices so what is wrong  if a same drug is produced by 100 companies.Let the best survive !

Remember drugs can not be compared with other commodities. Even in other sectors , there are restrictions .( You can not allow 100 flights in a same sector or 10 mobile phone companies in a single city ,  however free the economy is ! )Every drug and device company should have a moral and legal obligation not to reduplicate the already proven concepts. Many tend to masquerade as new concept with a very subtle difference.

What is the favorite game  played by the drug companies ?

It is a too competitive market out there in world pharma industry. Drugs and device are developed at huge cost.They have to spend billions of dollors for R &D. They need money. The  manpower , time and cost involved are enormous. A drug or device has to pass on many acid tests and hurdles before releasing into market.Even after releasing there is a very good chances of it being  recalled  in the first few years as real human data start pouring.Apart from these many drugs and devices fail to take off at various levels. There can be a huge financial loss.(Eg Torcirapid HDL reducing agent).

So what is the solution ?

Drug companies involve in futile research that is imitating already proven concepts .And a drug which was approved for one indication by FDA is tested for many other indications as it becomes easier for increasing the market  share.This is can be  called as  the  “Phenomenon of  drugs  looking for a  new indication” .This  against  spirit of clinical research .

The classical example is  the attempt to  widen the  indication  for statins , amiodarone ,  ( Aortic stenosis   etc )Instead our energy  should be focused   into  developing  drug  for incurable  diseases

When can duplication of research  be beneficial ?

Scientists are working hard for a total artificial heart for years.Many teams are pursuing different methodology and concepts. Here the  competition is welcome. Like this there are so many labs  trying to create a solution for a genuine medical issue.

Disclaimer

This article has nothing against any pharma industry. It aims to reason out the futility in medical research which is to be addressed for the betterment of human health.

Read related topic in my blog.

Can a Aim of a study be wrong ?

Annual workshops for interventional cardiologists has been  hugely popular events.They have  become the forum for all technological breakthroughs. Some of the popular ones are

Japanese have gained a unique place in  complex cardiovascular  therapeutics interventions especially in chronic occlusions.

Landmark article for CTO crossing

cto chronic total occlusion  Katoh coronary angiogram

www.cct.gr.jp/2003/wirehand/index.html

www.cct.gr.jp  cto japan

How to reach Japan ?

Click below

CCT2010

Myocardial infarction (STEMI)  occurs in two distinct arterial  territories .The anterior LAD circulation and postero- inferior RCA/LCX circulation.The incidence is equally shared.

There has been some  learned and unlearned perceptions about Inferior MI.

Inferior MI is less dangerous than anterior MI.  True or false ?

Answer: Essentially true in most situations.

Reasons.

Inferior wall of the heart (strictly speaking there is no walls for heart , only surfaces , which blends with adjacent areas)  inferior wall  is formed by diaphragmatic surface and posterior surface.Inferior MI can occur by either RCA or LCX obstruction.The outcome of inferior MI is determined by mainly by  the extent  of   LV myocardial   damage it inflicts.To  quantitate this  we need to know , how much of LV is supplied by RCA , or LCX or combination of both ? This depend on the coronary dominance .It is estimated , the bulk of the LV is supplied ( up to 75%  ) by LCA. This becomes further high in left dominant circulations . In fact , it is believed LV can never get involved in non dominant RCA occlusions. This has brought in a new terminology  called “Small inferior MI”.Inferior STEMI due to PDA  occlusion or in a co -dominant circulation is not yet studied

Apart from the above  anatomical considerations the following clinical observations  have  been made regarding inferior MI.

  • When thrombolysis was introduced , many studies  suggested the the ST elevation in inferior  leads toched the isolectric levels  in most situations even without thrombolysis.Technically, this implies spontaneous , successful thrombolysis are more common in RCA. Among the thrombolysed ,persistent ST elvation is a rare phenomenon.
  • The well known difference in the conduction defect between anterior and inferior MI  is an important contibutor for better outcome in the later.(AV blocks in inferior MI , are often transient, non progressive, supra hisian location rarely require permanent pacemakers)
  • During acute phase cardiogenic shock occurs in a minority (That too , only if RV shock is included )
  • Even in the follow up the ejection fraction in inferior MI is  almost always above  40%. In many EF is not affected at all.
  • Progressive adverse remodelling of LV is rare

When can Inferior MI be dangerous ?

Anatomical factors

Inspite of the  above  factors  inferior MI can not be taken lightly . Especially when it  extend into posterior, lateral , (Rarely anterior) segments.

While  posterior extension  is often  tolerated , lateral extension is very poorly tolerated .This is probably explained as  the extension involves the vital free wall of LV and the laplace forces could precipitate LVF. Free wall rupture is also common in this situation.

Posterior extension , predominantly involves the surface of RV which is less important hemodynamically. Of course incidence of MR  due to it’s effect on posterior mitral leaflet can be trouble some.

inferior MI ECG

High risk clinical catagories.

Out of hospital STEMI  are at  equal  risk irrespective of the territories involved  .This is because,  primary VF does not differentiate , whether  ischemia comes from RCA or LAD .

  1. In elderly , dibetics and co existing medical condtions  the the established  benign   character  of  inferior MI disappear, as  any  muscle loss  in LV has equally adverse outcome.
  2. Even though  inferior MIs are immune  to cardiogenic shock  , a equally worrisome  prolonged hypotension due to high vagal tone, bradycardia, plus or minus RVMI can create trouble. Fortunately , they respond better to  treatment. Except a few with extensive transmural RVMI outcome is good.
  3. Presence of  mechanical complications of  ventricular septal rupture , ischemic MR can bring  the mortality on par with large anterior MI.

How different is the clinical outcome of infero-posterior  MI with reference  to the  site of  coronary arterial  obstruction   ?

The sequence of  outcome  From  best to worse  : Non dominant RCA* → Dominant RCA but distal to RV branch → LCX dominant with large OMs

* It is believed   an  acute proximal  obstruction of a  non dominant RCA may not be mechanically significant, but can be electrically significant as it retains the risk of primary VF and SA nodal ischemia. The ECG changes  can be very minimal or  some times simple bradycardia is the only clue. One should be able to recognise this entity (Non dominant  RCA STEMI)  as the outcome is  excellent and these patients  would never require procedure like primary  PCI

** A inferior MI due to a dominant LCX and a large OMs have comparable outcome as that of extensive anterior MI. The ECG will reveal ST elevation in both inferior and lateral leads.

***In patients with prior CAD  and collateral dependent  multivessel disease  the  inferior anterior sub classification does not make much sense as  entire coronary circulation can be mutually interdependent.

Final message

Inferior STEMI  generally lacks the vigor  to cause extensive damage to myocardium in most situations .Further they respond better to treatment. Risk stratification of STEMI based on the location of MI has not been popular among mainstream cardiologists. This issue needs some introspection as  the costly and complex treatment modalities like primary PCI  is unwarranted in most of the low risk inferior MIs.

Related posts in my blog:

1.Why thrombolysis is more effective in RCA?

Total coronary artery occlusion is a common finding in CAD  especially in chronic stable angina. Normal coronary blood flow is 5 % of cardiac output  that amounts to 250-300ml/mt.At an average  heart rate of  70/mt  , each  beat  injects  about 5cc blood into the coronary circulation.This is shared between two coronary arteries.  This means , only few CC (2-3cc) of blood enters  each coronary artery with each cardiac cycle .

When one of coronary artery is totally occluded what happens to the coronary

blood flow ?

A.Total coronary blood flow  can be be  maintained   normal  at rest  as it  forms  only about 5% of cardiac output  (or it is only  slightly reduced )

B. It is believed , the unobstructed coronary artery  could receive the blood meant for the contralateral coronary artery. This  possibly explains the increased coronary artery diameter in the non obstructed artery.

C. It’s nature’s wish ,  that the  contralateral  coronary artery  shall share  50% of  it’s  blood through  collaterals if available.

D.If collaterals are not formed it , the unobstructed coronary  artery  may be over perfused with double the amount  of blood flow.

E. Some times , the collaterals steal  much more than what  the  obstructed coronary artery  deserves and make the feeding coronary artery ischemic. This is many times observed in  total RCA occlusion with well formed  collaterals  from LAD/LCX.

F.The collateral flow  in CTO also depend on whether flow is directed from LAD system to RCA or from RCA -LAD system. The LAD is better placed to assist RCA than vice versa.This is for two reasons.1.LAD blood flow is higher than RCA so it can share it.2.The driving pressure is more  from LAD -RCA , as RCA can receive  blood flow even during diastole .

F.During exertion , the coronary hemodynamics become further complex.The collateral’s are traditionally thought to be less than adequate during times of exercise.But it is more of a perception than solid scientific data.This rule  may be applicable in only certain group of patients. We know CTO patients with very good exercise tolerance who have documented collateral’s.

G.Collaterals can be either  visible or invisible by CAG. The strength of collateral circulation is not in it’s visibility but it’s capacity to dilate and  respond to neuro humoral mediators at times of  demand.  Currently  , there is lot to be desired  regarding  our knowledge about  the physiology  of visible collaterals , no need to  mention about invisible collaterals !

Final message

The above statements  are based  on logics and observations .

Is it not a  irony  in cardiac literature ,  where  thousands of articles  are coming out every month  to tackle  totally occluded coronary artery(CTOs) ,  there is  very little data   regarding the coronary hemodynamics in chronic total occlusion .   How  does a patient with CTO can manage a active life with only one functioning  coronary artery ?

Thanks to wordpress.This  blog has caught the attention of some professional sites.

I was interviewed   by Jodie Elrod on behalf  of   EP lab digest July 09 Issue

dr s venkatesan www.drsvenkatesan.com